• KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

Read All the News
01-09-2022
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
Read all
28-07-2022
Kedrion alongside the World Hepatitis Alliance
The company is proud to support WHA’s initiative aimed at preventing mother-to-child transmission (PMTCT) of Hepatitis B
Read all
28-06-2022
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
Read all
2021 Annual report
Pharmacovigilance
Medical & Scientific Information
VIDEO-GALLERY